α-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy
Jungyeon Hwang1, Kathleen Rodgers2, James C Oliver3, Thomas Schluep11Insert Therapeutics, Inc., Pasadena, CA, USA; 2Livingston Research Institute, Los Angeles, CA, USA; James C Oliver, Peptagen, Inc., Raleigh, NC USAAbstract: A glycinate derivative of α-methylprednisolone (MP) was prep...
Guardado en:
Autores principales: | Jungyeon Hwang, Kathleen Rodgers, James C Oliver, Thomas Schluep |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25cabd130b424973a99846497d2ca988 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy
por: Hubert Marotte, et al.
Publicado: (2008) -
Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-α therapy for rheumatoid arthritis
por: Shu Kachi, et al.
Publicado: (2010) -
Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure
por: Kekow J, et al.
Publicado: (2012) -
Methyl-β-cyclodextrin quaternary ammonium chitosan conjugate: nanoparticles vs macromolecular soluble complex
por: Piras AM, et al.
Publicado: (2018) -
Synthesis and biological evaluation of novel β-cyclodextrin-fluvastatin conjugates
por: Mariacristina Nicolosi, et al.
Publicado: (2021)